alternatives to glp-1 agonists Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research GLP-1 Receptor Agonists: Mascots &
Description
Reduce or eliminate processed foods, excess added sugars, and vegetable oils
Recent advances in incretin-based therapy for MASLD: from single to dual or triple incretin receptor agonists
The LEAN trial with liraglutide and a phase 2 trial of semaglutide in patients with non-alcoholic steatohepatitis (NASH) showed improvements in liver histology and reductions in hepatic inflammation markers
doi: 10.1016/S2213-8587(22)00349-7
One human study did report an acute decrease of diet-induced thermogenesis due to lower carbohydrate oxidation following i.v
Intervention through lifestyle modification remains the first-line therapeutic strategy
